In addition, we also noted that the inner retinal nasal-to-fovea thickness decreased and there was significant atrophy 5 months after the second anti-VEGF treatment, which may have been the natural change observed in the course of CRAO[38] or the effect of anti-VEGF treatment. This evidence concerns the gene VEGFA and Atrophy.